Total Debt
$21.6M
Net Debt
-$934.8M
Janux Therapeutics, Inc. currently has $21.6M in total debt. Net debt is -$934.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
JANX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.02 | 0.96 | -0.93Net Cash | 1.03 | 2.1% |
| 2025-12-31 | 0.02 | 0.97 | -0.94Net Cash | 1.01 | 2.2% |
| 2025-09-30 | 0.02 | 0.99 | -0.97Net Cash | 1.02 | 2.2% |
| 2025-06-30 | 0.02 | 1.00 | -0.97Net Cash | 1.03 | 2.1% |
| 2025-03-31 | 0.02 | 1.01 | -0.99Net Cash | 1.05 | 2.2% |
| 2024-12-31 | 0.02 | 1.03 | -1.00Net Cash | 1.06 | 2.2% |
| 2024-09-30 | 0.02 | 0.66 | -0.63Net Cash | 0.70 | 3.4% |
| 2024-06-30 | 0.02 | 0.65 | -0.62Net Cash | 0.69 | 3.4% |
| 2024-03-31 | 0.02 | 0.65 | -0.63Net Cash | 0.69 | 3.5% |
| 2023-12-31 | 0.02 | 0.34 | -0.32Net Cash | 0.38 | 6.5% |
| 2023-09-30 | 0.02 | 0.35 | -0.32Net Cash | 0.39 | 6.4% |
| 2023-06-30 | 0.03 | 0.30 | -0.28Net Cash | 0.34 | 7.4% |
| 2023-03-31 | 0.03 | 0.32 | -0.29Net Cash | 0.35 | 7.2% |
| 2022-12-31 | 0.03 | 0.33 | -0.30Net Cash | 0.36 | 7.0% |
| 2022-09-30 | 0.02 | 0.34 | -0.31Net Cash | 0.38 | 6.4% |
| 2022-06-30 | 0.02 | 0.35 | -0.33Net Cash | 0.39 | 6.1% |
| 2022-03-31 | 0.00 | 0.36 | -0.36Net Cash | 0.37 | 0.0% |
| 2021-12-31 | 0.00 | 0.37 | -0.37Net Cash | 0.38 | 0.1% |
| 2021-09-30 | 0.00 | 0.39 | -0.39Net Cash | 0.39 | 0.1% |
| 2021-06-30 | 0.00 | 0.39 | -0.39Net Cash | 0.40 | 0.0% |
| 2021-03-31 | 0.00 | 0.07 | -0.07Net Cash | 0.07 | 0.0% |
| 2020-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.02 | 0.0% |